These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18798714)

  • 21. Anti-inflammatory effects of levosimendan in decompensated heart failure: impact on weight loss and anemia.
    Parissis JT; Farmakis D; Kremastinos DT
    Am J Cardiol; 2005 Apr; 95(7):923-4. PubMed ID: 15781038
    [No Abstract]   [Full Text] [Related]  

  • 22. [Levosimendan as inotropic support during coronary surgery with extracorporeal circulation in a patient with severely depressed ventricular function].
    Delange Segura L; Jerez Anera M; Carmona Aurioles J; Rodríguez Fernández S
    Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):423-4. PubMed ID: 14601372
    [No Abstract]   [Full Text] [Related]  

  • 23. Perioperative use of levosimendan: best practice in operative settings.
    Toller W; Algotsson L; Guarracino F; Hörmann C; Knotzer J; Lehmann A; Rajek A; Salmenperä M; Schirmer U; Tritapepe L; Weis F; Landoni G
    J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):361-6. PubMed ID: 22658687
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of Levosimendan for myocardiopathy due to acute Chagas' disease.
    de March Ronsoni R; Feijó RV; Melo LH; Schwingel FL; Filho WJ; de Albernaz Muniz RZ; Weber S; Moro A
    Int J Cardiol; 2009 Aug; 136(2):233-5. PubMed ID: 18662834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of levosimendan on the energy balance: preclinical and clinical evidence.
    Nieminen MS; Pollesello P; Vajda G; Papp Z
    J Cardiovasc Pharmacol; 2009 Apr; 53(4):302-10. PubMed ID: 19276987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levosimendan in septic shock: a case series.
    Powell BP; De Keulenaer BL
    Br J Anaesth; 2007 Sep; 99(3):447-8. PubMed ID: 17702832
    [No Abstract]   [Full Text] [Related]  

  • 27. Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan.
    Papp Z; Édes I; Fruhwald S; De Hert SG; Salmenperä M; Leppikangas H; Mebazaa A; Landoni G; Grossini E; Caimmi P; Morelli A; Guarracino F; Schwinger RH; Meyer S; Algotsson L; Wikström BG; Jörgensen K; Filippatos G; Parissis JT; González MJ; Parkhomenko A; Yilmaz MB; Kivikko M; Pollesello P; Follath F
    Int J Cardiol; 2012 Aug; 159(2):82-7. PubMed ID: 21784540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levosimendan: new indications and evidence for reduction in perioperative mortality?
    Pisano A; Monti G; Landoni G
    Curr Opin Anaesthesiol; 2016 Aug; 29(4):454-61. PubMed ID: 27168089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [If the myofilaments become sensitive: Ca2+-sensitizer for the therapy of heart insufficiency].
    Schwinger RH; Brixius K
    Dtsch Med Wochenschr; 2005 Apr; 130(15):969-73. PubMed ID: 15812725
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical outcome benefits of pretreatment with levosimendan.
    van den Brule J; Hoedemaekers C; Pickkers P
    Br J Anaesth; 2009 Jun; 102(6):883-4; author reply 884. PubMed ID: 19451156
    [No Abstract]   [Full Text] [Related]  

  • 31. Levosimendan in perioperative and critical care patients.
    Salmenperä M; Eriksson H
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):496-501. PubMed ID: 19502977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The preconditioning effects of levosimendan.
    Kumar S; Kumar A; De Santis V
    Br J Anaesth; 2006 Sep; 97(3):425; author reply 425. PubMed ID: 16896199
    [No Abstract]   [Full Text] [Related]  

  • 33. Levosimendan.
    Mason P
    Intensive Crit Care Nurs; 2003 Dec; 19(6):370-1. PubMed ID: 14637297
    [No Abstract]   [Full Text] [Related]  

  • 34. Levosimendan and calcium sensitization of the contractile proteins in cardiac muscle: impact on heart failure.
    Kota B; Prasad AS; Economides C; Singh BN
    J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):269-78. PubMed ID: 19087950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levosimendan in acute pulmonary embolism.
    Powell BP; Simes D
    Anaesth Intensive Care; 2007 Oct; 35(5):771-2. PubMed ID: 17933166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BET 1: levosimendan in septic shock.
    Coates J; Mathieu S
    Emerg Med J; 2014 Jun; 31(6):508-10. PubMed ID: 24839073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levosimendan for treatment of septic shock: homeotherapy or inadequate therapy?
    Yang JJ; Ji MH; Sun J; Peng YG
    Acta Anaesthesiol Scand; 2011 Oct; 55(9):1147; author reply 1147-8. PubMed ID: 22092214
    [No Abstract]   [Full Text] [Related]  

  • 38. Levosimendan: current status and future prospects.
    Archan S; Toller W
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levosimendan and quality of life.
    Papadopoulos CE; Zioutas DG; Dalamaga EG
    Hellenic J Cardiol; 2010; 51(1):81-2. PubMed ID: 20118051
    [No Abstract]   [Full Text] [Related]  

  • 40. Levosimendan in cardiogenic shock: better than enoximone!
    Buerke M; Prondzinsky R
    Crit Care Med; 2008 Aug; 36(8):2450-1. PubMed ID: 18664796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.